Mark Perreault

Mark Perreault is the director of membrane application development for TangenX technology at Novasep

Using a pre-sanitized disposable TFF membrane in the DSP of biopharmaceuticals makes it possible to reduce labor by 50% and buffer/water usage by 75%. In addition, it can increase productivity by more than 45%. This economic model compares the costs of reusable and single-use TFF in biopharmaceutical applications.

Single-use TFF offers the greatest savings in clinical and contract manufacturing, where the scale is low and changeovers are frequent.